These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
679 related articles for article (PubMed ID: 15638236)
1. Infliximab in the treatment of steroid-dependent ulcerative colitis. Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients. Gavalas E; Kountouras J; Stergiopoulos C; Zavos C; Gisakis D; Nikolaidis N; Giouleme O; Chatzopoulos D; Kapetanakis N Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042 [TBL] [Abstract][Full Text] [Related]
3. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis]. Mocciaro F; Orlando A; Scimeca D; Cottone M Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405 [TBL] [Abstract][Full Text] [Related]
4. A review of infliximab use in ulcerative colitis. Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261 [TBL] [Abstract][Full Text] [Related]
5. Infliximab in the treatment of severe ulcerative colitis: a follow-up study. Kohn A; Prantera C; Pera A; Cosintino R; Sostegni R; Daperno M Eur Rev Med Pharmacol Sci; 2004; 8(5):235-7. PubMed ID: 15638237 [TBL] [Abstract][Full Text] [Related]
6. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316 [TBL] [Abstract][Full Text] [Related]
7. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. Fanjiang G; Russell GH; Katz AJ J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441 [TBL] [Abstract][Full Text] [Related]
9. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Jakobovits SL; Jewell DP; Travis SP Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506 [TBL] [Abstract][Full Text] [Related]
10. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids. Yamamoto-Furusho JK; Uzcanga LF Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257 [TBL] [Abstract][Full Text] [Related]
12. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442 [TBL] [Abstract][Full Text] [Related]
14. Infliximab for ulcerative colitis in children and adolescents. McGinnis JK; Murray KF J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529 [TBL] [Abstract][Full Text] [Related]
15. Review article: the management of steroid dependency in ulcerative colitis. Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462 [TBL] [Abstract][Full Text] [Related]
16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
17. Outcome of a conservative approach in severe ulcerative colitis. Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812 [TBL] [Abstract][Full Text] [Related]
18. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735 [TBL] [Abstract][Full Text] [Related]
19. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF; Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]